The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUBX.L Regulatory News (SUBX)

  • There is currently no data for SUBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Outcome of the Board Meeting held on May 29, 2014

30 May 2014 07:03

RNS Number : 4309I
Subex Limited
30 May 2014
 



 

 

 

 

May 30, 2014

 

To

 

The London Stock Exchange

10 Paternoster Square

London

EC4M 7LS Dear Sirs,

Sub: Outcome of the Board Meeting held on May 29, 2014

 

Please be informed that the following important item was discussed and approved at the Board Meeting held on May 29, 2014:

· Audited standalone and consolidated Financial Results of the Company for the year ended March 31, 2014.

 

   

We request you to take the aforesaid notification on record.

 

 

 

Yours faithfully

For and on behalf of Subex Limited

 

 

 

 

Ganesh K V

Global Head - Finance, Legal and Company Secretary

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBEX LTD

Registered office: RMZ Ecoworld, Outer Ring Road, Devarabisanahalli, Bangalore - 560 037

Statement of Consolidated Audited Results for the Quarter and year ended March 31 2014

PART - I (Rs. In Lakhs except per share data)

CONSOLIDATED

Particulars

Three Months ended

Preceding 3 months ended

Corresponding 3 months ended

For the year ended

Previous Year ended

31/03/2014

31/12/2013

31/03/2013

31/03/2014

31/03/2013

 

 

 

1

 

 

 

 

 

 

 

 

2

(a)

(b)

(c)

(d)

(e)

 

 

 

3

 

 

 

 

4

 

 

5

 

 

6

(a)

(b)

(c)

 

 

7

 

 

 

8

 

 

9

 

 

 

10

 

 

11

 

 

 

Income From Operations:

Net Sales/ Income From Operations Product & Product related Services

Audited (Refer Note 12)

Unaudited

Audited (Refer Note 12)

Audited

Audited

 

 

 

8,541

-

 

 

 

9,144

-

 

 

 

7,959

37

 

 

 

34,005

-

 

 

 

30,734

2,324

Total Income From Operations (Net)

8,541

9,144

7,996

34,005

33,058

 

Expenses:

Cost of Hardware, Software & Services

Employee Benefits Expense and Sub-contract charges Other Expenditure

Depreciation and Amortisation Expense Exchange Fluctuation (Gain)/Loss-Net

 

 

 

286

4,417

2,041

63

1,084

 

 

 

202

4,544

1,753

60

1,379

 

 

 

197

4,186

1,569

87

441

 

 

 

956

17,929

6,893

248

1,677

 

 

 

817

20,669

6,981

427

655

Total Expenses

7,891

7,938

6,480

27,703

29,549

Profit / (Loss) From Operations before Other Income, Finance costs and Exceptional items (1-2)

650

1,206

1,516

6,302

3,509

 

 

Other Income

 

 

578

 

 

3

 

 

12

 

 

450

 

 

89

Profit / (Loss) From Ordinary activities before Finance costs and Exceptional items (3+4)

1,228

1,209

1,528

6,752

3,598

Finance Costs

Interest on FCCB ( Refer Note 10) Interest on Term Loan ( Refer Note 10) Other Borrowing Cost

 

886

219

558

 

896

215

651

 

775

112

755

 

3,422

840

2,486

 

2,212

386

2,612

Profit / (Loss) From Ordinary activities after Finance costs but before Exceptional items (5+6)

(435)

(553)

(114)

4

(1,612)

 

Exceptional Items (Refer Note 2)

 

220

 

-

 

-

 

220

 

3,997

Profit / (Loss) From Ordinary activities before Tax (7+8)

(655)

(553)

(114)

(216)

(5,609)

 

 

Tax Expense (Net)

 

 

#REF!

 

 

291

 

 

43

 

 

#REF!

 

 

386

Net Profit / (Loss) From Ordinary activities after Tax (9+10)

(Refer Note 4 )

#REF!

(844)

(157)

#REF!

(5,995)

12

 

 

13

Paid up Share Capital

- Equity (Face value of Rs. 10/-)

Reserve excluding Revaluation Reserves as per balance sheet of previous accounting year

 

 

16,664

 

 

-

 

 

16,664

 

 

-

 

 

16,664

 

 

-

 

 

16,664

 

 

698

 

 

16,664

 

 

5,836

14

Earnings per share (before extraordinary items) (of Rs. 10/- each) (not annualised in case of the interim periods):

Basic Diluted

 

 

 

(0.73)

(0.73)

 

 

 

(0.51)

(0.51)

 

 

 

(0.01)

(0.01)

 

 

 

(0.70)

(0.70)

 

 

 

(4.40)

(4.40)

PART - II

A

1

 

 

 

 

 

2

PARTICULARS OF SHAREHOLDING

Aggregate of Public shareholding:*

Number of shares

Percentage of holding (to total shareholding)

 

 

Promoters and promoter group

Shareholding

a) Pledged/Encumbered

- Number of shares

- Percentage of shares (as a % of the total shareholding of

 

 

promoter and promoter group)

- Percentage of shares (as a% of the total share capital of the

company)

b) Non-encumbered

- Number of Shares

- Percentage of shares (as a% of the total shareholding of

 

 

promoter and promoter group)

- Percentage of shares (as a % of the total share capital of the

company)

 

 

 

158,366,608

95.04%

 

 

 

 

 

 

6,474,044

 

 

100.00%

 

 

 

3.89%

 

 

 

- 0.00%

 

0.00%

 

 

 

158,366,608

95.04%

 

 

 

 

 

 

6,474,044

 

 

100.00%

 

 

 

3.89%

 

 

 

- 0.00%

 

0.00%

 

 

 

149,946,715

89.98%

 

 

 

 

 

 

8,474,044

 

 

100.00%

 

 

 

5.09%

 

 

 

- 0.00%

 

0.00%

 

 

 

158,366,608

95.04%

 

 

 

 

 

 

6,474,044

 

 

100.00%

 

 

 

3.89%

 

 

 

- 0.00%

 

0.00%

 

 

 

149,946,715

89.98%

 

 

 

 

 

 

8,474,044

 

 

100.00%

 

 

 

5.09%

 

 

 

- 0.00%

 

0.00%

* Total public shareholding as defined under clause 40A of the listing agreement (excludes underlying shares for GDRs)

 

Global Depository Reciepts

Three Months ended 31/03/2014

Preceding 3 months ended 31/12/2013

Corresponding 3 months ended 31/03/2013

For the year ended 31/03/2014

For the Twelve Months ended 31/03/2013

- Number of underlying Equity Shares

- Percentage of Share Holding

17,99,310

1,799,310

6,989,399

17,99,310

69,89,399

1.08%

1.08%

4.19%

1.08%

4.19%

 

 

 

 

 

 

B

 

 

 

 

 

 

 

STATEMENT OF ASSETS AND LIABILITIES Rs. in Lakhs

 

 

A 1

(a)

(b)

 

 

2

(a)

(b)

(c)

(d)

 

 

 

3

(a)

(b)

(c)

(d)

 

 

 

 

B

1

(a)

(b)

(c)

(d)

(e)

 

 

2

(a)

(b)

(c)

(d)

Particulars

As At

As At

31/03/2014

31/03/2013

Audited

Audited

EQUITY AND LIABILITIES

 

Shareholders' Funds

Share capital Reserves and Surplus

Sub-total - Shareholders' funds Non-current Liabilities

Long-term Borrowings

Deferred Tax Liabilities(net) Other Long-term Liabilities Long-term Provisions

Sub-total - Non-current liabilities

 

 

Current Liabilities

Short-term Borrowings

Trade Payables - Other than acceptances Other Current Liabilities

Short-term Provisions

Sub-total - Current liabilities

 

 

 

 

16,664

698

 

 

 

 

16,664

5,836

17,362

 

60,245

- 5,546

602

22,500

 

53,769

- 533

554

66,393

 

 

 

16,016

5,253

4,061

349

54,856

 

 

 

19,388

4,864

6,842

348

25,679

31,442

TOTAL - EQUITY AND LIABILITIES (1+2+3)

109,434

108,798

ASSETS

Non-current Assets

Fixed Assets

Goodwill on Consolidation Deferred tax assets (net)

Long-term Loans & Advances Other Non-current Assets

Sub-total - Non-current assets

 

Current Assets

Trade Receivables

Cash and Bank Balances

Short-term Loans & Advances Other Current Assets

Sub-total - Current assets

 

 

598

85,642

- 2,412

1,425

 

 

467

85,642

141

2,646

1,314

90,077

 

 

10,058

4,793

949

3,557

90,210

 

 

7,333

5,083

998

5,174

19,357

18,588

TOTAL - ASSETS (1+2)

109,434

108,798

 

Notes :

1

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4

The above results have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on May 29th, 2014.

 

Exceptional items comprise - Rs in Lakhs

 

 

Particulars

Three Months ended 31/03/2014

Preceding 3 months ended 31/12/2013

Corresponding 3 months ended 31/03/2013

For the year ended 31/03/2014

Previous Year ended 31/03/2013

Audited (Refer Note 12)

 

Unaudited

Audited (Refer Note 12)

 

Audited

 

Audited

Goodwill Impairment*

-

-

-

-

927

Exceptional Provision for Doubtful trade and other receivables**/#

220

-

-

220

3,070

TOTAL

220

-

-

220

3,997

\* The company had impaired goodwill outstanding in books pertaining to its services business during the year ended March 31, 2013. As an impairment in goodwill is not considered to be regular adjustment in the results, the same had been categorised as an exceptional item.

**During the year ended March 31, 2013, the Company had carried out an assessment of its receivables and an amount of Rs. 3,070 lakhs had been provided towards doubtful receivables. Considering that the amount of provision towards doubtful receivables was significant and relevant in understanding the financial performance, it had been disclosed separately under exceptional item.

# Represents provisions relating to Services segment discontinued with effect from 01.04.2013

Summary of key standalone financial results is as follows: Rs in Lakhs

 

 

 

Particulars

Three Months ended 31/03/2014

Preceding 3 months ended 31/12/2013

Corresponding 3 months ended 31/03/2013

For the year ended 31/03/2014

Previous Year ended 31/03/2013

Audited (Refer

Note 12)

Unaudited

Audited (Refer

Note 12)

Audited

Audited

Net Sales/ Income from Operations

7,340

8,203

6,942

29,367

26,556

Profit / (Loss) from ordinary activities before tax

(2,316)

(671)

(636)

(2,806)

(3,457)

Profit / (Loss) from ordinary activities after tax

(2,683)

(799)

(636)

(2,953)

(3,457)

As permitted under the Proposal approved by the Hon'ble High Court of Karnataka, which was given effect in the year ended March 31, 2011, the Company transferred certain amounts standing to the credit of Capital Reserve to the Business Restructuring Reserve (BRR) and utilised the same for permitted utilisations as under. Had the Proposal not provided for the above accounting treatment :

(Rs in Lakhs except per share data)

 

 

 

Particulars

Three Months ended 31/03/2014

Preceding 3 months ended 31/12/2013

Corresponding 3 months ended 31/03/2013

For the year ended 31/03/2014

Previous Year ended 31/03/2013

Audited (Refer Note 12)

Unaudited

Audited (Refer Note 12)

Audited

Audited

Revenue would have been lower by

Other Expenditure would have been higher by

Expenses termed as Exceptional Items would have been higher /(lower) by

Net (loss) / profit would have been (higher) / lower by

-

-

 

-

 

 

-

-

-

 

-

 

 

-

-

-

 

-

- 81

 

-

 

 

(81)

959

- 359

(1,318)

Earnings / ( Loss) Per Share would have been

-Basic

- Diluted

 

(0.73)

(0.73)

 

(0.51)

(0.51)

 

(0.01)

(0.01)

 

(0.75)

(0.75)

 

(5.35)

(5.35)

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6

 

 

 

7

Pursuant to the approval of the holders of "US$ 180 Million 2% convertible unsecured bonds", [of which US$ 39 Million was outstanding ("FCCBs I")] and "US$ 98.7 Million 5% convertible unsecured bonds", [of which US$ 54.8 was outstanding ("FCCBs II")], at their respective meetings held on July 5, 2012 and exchange offers received under the exchange offer memorandum dated June 13, 2012, holders of US$ 38 Million out of FCCBs I and US$ 53.4 Million out of FCCBs II offered their bonds for exchange. Consequently, secured bonds of US$ 127.721 million ("FCCBs III") were issued with maturity date of July 7, 2017, having a conversion price of Rs.22.79 per equity share and coupon of 5.70% p.a. payable semi-annually on the outstanding bonds. In accordance with the terms of FCCBs III, principal amount of US$ 36.321 Million were mandatorily converted into equity shares at the aforesaid conversion price in July 2012. The company has been legally advised that there is no tax incidence arising from the above restructuring. Further, the maturity period of the un-exchanged portion of FCCBs I of US$ 1 Million and FCCBs II of US$ 1.4 Million stands extended to March 9, 2017, with its other terms and conditions remaining unchanged.

The Company has issued 72,55,848 equity shares upon conversion of FCCBs of principal amount of US$ 29,50,000 by the holder(s) of Company's US$ 91.10 million 5.70% Convertible Secured Bonds. Post the conversion, FCCBs aggregating to US$ 88.15 million are outstanding under the said Bonds.

There have been no conversions during the quarter.

 

During the year ended March 31, 2014 , the Company has assessed the carrying value of goodwill arising from its investment in its subsidiary viz. Subex Americas Inc., amounting to Rs.18,606 Lakhs. Based on the management's assessment, there is no impairment of such goodwill taking into account the future operational plans and cash flows as prepared by the management and accordingly, no impairment loss is required to be recognized at this stage.

 

The excess of the managerial remuneration paid to the directors over the limits prescribed in Schedule XIII of the Companies Act, 1956 for the financial year ended March 31, 2013 amounting to Rs.124 Lakhs is being treated as monies due from such directors, considered as recoverable and being held by them in trust for and behalf of the Company.The Company has taken necessary steps for recovery of the above amounts and these items along with other claims are a subject matter of arbitration which is in progress.

8

 

 

 

 

 

 

 

 

 

 

1

(a)

(b)

 

 

 

2

(a)

(b)

 

 

 

 

 

 

(a)

(b)

 

 

 

 

3

SEGMENT REPORTING: (Rs in Lakhs)

 

 

 

 

 

 

 

 

Segment Revenue: Products & Product related Services ( Refer Note 9)

Consolidated

Three Months ended

Preceding 3 months ended

Corresponding 3 months ended

For the year ended

Previous Year ended

31/03/2014

31/12/2013

31/03/2013

31/03/2014

31/03/2013

Audited (Refer Note 12)

 

 

Unaudited

Audited (Refer Note 12)

 

 

Audited

 

 

Audited

 

8,541

-

 

9,144

-

 

7,959

37

 

34,005

-

 

30,734

2,324

8,541

9,144

 

 

 

1,264

-

7,996

 

 

 

1,644

(116)

34,005

 

 

 

6,935

-

33,058

 

 

 

4,203

(605)

Segment Profit/(Loss) before tax, interest & exceptional Items

Products & Product related Services ( Refer Note 9)

 

Less: Interest (Net)

Less : Other Unallocable expenses Less : Exceptional items [Net] Products & Product related Services

 

Profit Before Taxation

 

 

Details of Capital Employed

(a) Product & Product related

 

 

(b) Services ( Refer Note 9)

 

 

(c) Unallocated

1,248

-

1,248

1,626

57

220

-

-

 

(655)

 

 

 

99,162

 

 

- (81,801)

1,264

1,762

55

 

-

-

 

 

(553)

 

 

 

98,862

 

 

230

 

 

(83,327)

1,528

1,642

-

 

-

-

 

 

(114)

 

 

 

97,200

 

 

(267)

 

 

(74,434)

6,935

6,710

221

220

-

 

 

 

(216)

 

 

 

99,163

 

 

- (81,801)

3,598

5,210

-

 

3,070

927

 

 

(5,609)

 

 

 

97,200

 

 

(267)

 

 

(74,434)

9

 

10

 

 

 

11

12

 

 

13

The Services business has been discontinued with effect from 01.04.2013.

 

Finance Cost includes deferred interest on FCCB amounting to Rs. 3422 lakhs and Rs. 886 lakhs in respect of year and quarter ended 31st March 2014 respectively, the same being payable on redemption on 7th July 2017. Further interest on term loan amounting to Rs.408 lakhs and Rs.107 lakhs in respect of year and quarter ended 31st March 2014 respectively is due to be paid in 21st August 2016.

Previous period / year figures have been re-grouped and/or re-arranged to conform with the current period.

The figures of the last quarter are the balancing figures between the audited figures in respect of the full financial year and the published year to date figures upto the third quarter of the relevant financial year.

Pursuant to clause 41 of the Listing Agreement, the Company has opted to publish the consolidated financial results. The standalone financial results, however, are being made available to the Stock Exchanges where the securities of the Company are listed and are also being posted on the Company's website www.subex.com.

Certain statements in this release concerning our performance may be forward looking statements which involve risks and uncertainties that could cause actual results to vary materially from those in such statements. These risks and uncertainties include, and are not limited to, fluctuations in earnings, intense competition and success of investments

By Order of the Board

 

Mumbai

Date: 29th May, 2014 Surjeet Singh

Managing Director & CEO

For further details on the results, please visit our website: www.subex.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMQKKDPPBKKCPN
Date   Source Headline
9th Aug 202210:35 amRNSOutcome of the Board Meeting held on August 8,2022
30th Jun 20223:42 pmRNSProposed termination of GDRs & De-listing
1st Jun 202211:52 amRNSOutcome of Board Meeting dated May 30, 2022
1st Feb 202211:11 amRNSOutcome of Board Meeting held on Jan 31, 2022
29th Oct 20218:37 amRNSOutcome of Board Meeting held on October 28, 2021
10th Aug 202111:41 amRNSOutcome of the Board Meeting on August 09, 2021
15th Jun 202111:56 amRNSNotice of Twenty Seventh Annual General Meeting
18th May 202111:20 amRNSOutcome of the Board Meeting held on May 17, 2021
2nd Feb 202112:38 pmRNSOutcome of the Board Meeting February 01,2021
10th Nov 202011:32 amRNSOutcome of the Board Meeting November 09,2020
1st Sep 202012:01 pmRNSNotice of the Twenty Sixth Annual General Meeting
11th Aug 20202:34 pmRNSOutcome of Board Meeting on August 10, 2020
12th May 20207:31 amRNSSubex Limited-Outcome of Board Meeting 11 May 2020
12th Feb 20207:00 amRNSOutcome of the Board Meeting of Subex Limited
11th Nov 201910:17 amRNSResults for quarter & half year ended Sep 30, 2019
13th Aug 201911:02 amRNSOutcome of the Board Meeting - August 12, 2019
10th Jun 201911:55 amRNSNotice of the Twenty Fifth Annual General Meeting
14th May 20199:51 amRNSSubex Limited Outcome -Board Meeting -May 13, 2019
30th Jan 20197:00 amRNSOutcome of the Board Meeting held on Jan 29, 2019
2nd Nov 20187:08 amRNSOutcome of the Board Meeting- October 31, 2018
1st Aug 20187:00 amRNS1st Quarter Results
12th Jul 20187:26 amRNSThe Twenty Fourth AGM of Subex Limited
27th Jun 20187:38 amRNSSubex Limited-Outcome -Board Meeting June 26,2018
4th May 20183:00 pmRNSFinal Results
22nd Mar 201811:29 amRNSAppointment of MD & CEO of Subex Ltd
30th Jan 20189:50 amRNSFinancial Results - 3rd Quarter
13th Nov 201710:01 amRNSOutcome of Board Meeting held on November 10 2017
2nd Nov 201711:54 amRNSRestructuring of the Business wef Nov 1, 2017
5th Oct 20177:00 amRNSOutcome of Board Meeting held on October 4, 2017
22nd Aug 201711:47 amRNSOutcome of Board Meeting held on August 21, 2017
31st Jul 201711:38 amRNS1st Quarter Results
10th Jul 201711:40 amRNSRedemption of FCCB III
4th Jul 201711:05 amRNSNotice of AGM
5th Jun 201711:25 amRNSOutcome of the Board Meeting held on June 05, 2017
5th Jun 201711:15 amRNSOutcome of the Board Meeting held on June 05, 2017
26th May 20177:00 amRNSFinal Results
24th Mar 201711:41 amRNSOutcome of the Board Meeting held on March 24 2017
7th Mar 20178:26 amRNSIntimation on Redemption of FCCBs
3rd Feb 201710:46 amRNSSubex Limited 3rd Quarter Results
7th Dec 20167:50 amRNSOutcome of Board Meeting held on December 06 2016
14th Sep 20167:47 amRNS1st Quarter Results
22nd Aug 201611:14 amRNSNotice of AGM
10th Aug 201610:43 amRNSOutcome of the Board Meeting- August 9, 2016
25th May 201610:51 amRNSSubex Limited-Outcome of Board Meeting
11th Feb 201612:18 pmRNS3rd Quarter Results
3rd Nov 20152:44 pmRNSResult of Meeting
27th Aug 20158:45 amRNSSubex Limited (The Company)-Update
13th Aug 20152:00 pmRNS1st Quarter Results
3rd Jul 201511:55 amRNSNotice of the Outcome of Bondholders meeting
27th May 201512:44 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.